Explore News By Topic



June 24, 2015 -- Tumor cells are continuously evolving to adapt to selective pressures introduced by changing host factors and the administration of new therapies. Following treatment with second-generation anti-androgen therapies abiraterone acetate (Zytiga®) and enzalutamide (Xtandi®), prostate tumors inevitably develop resistance and progress to lethal disease. Anti-androgen therapy-resistant prostate.


Surgery May Beat Radiation for Men With Early Stage Prostate Cancer

TUESDAY, Dec. 15, 2015 (HealthDay News) -- Men with prostate cancer that's still confined to the organ are more likely to survive if they have surgery rather than radiation therapy, a new Canadian study suggests. This type of "localized" prostate cancer is the most common form of the disease, accounting.


Low-Risk Prostate Cancer Often Not Monitored Closely

Friday, Dec. 4, 2015 (HealthDay News) -- Most men with low-risk prostate cancer who choose "watchful waiting" instead of aggressive treatment may not be followed as closely as they should be, a new study suggests. This puts them in danger of their cancer progressing or spreading undetected, the researchers warned..


Sweat to Help Reduce Your Risk for Prostate Cancer

Nov. 27, 2015 (HealthDay News) -- Vigorous exercise, a healthy diet and not smoking may dramatically reduce a man's risk for aggressive prostate cancer, new research suggests. Nearly half of lethal prostate cancer cases in the United States would be prevented if men over 60 followed five or more healthy.


Yoga May Boost Quality Of Life For Prostate Cancer Patients

Nov. 20, 2015 (HealthDay News) -- Yoga may benefit men who are undergoing radiation therapy for prostate cancer, according to a small study. Many such patients experience side effects, including fatigue, erectile dysfunction, urinary incontinence and a decline in their quality of life, the researchers said. The new study included.


Black Men May Get Worse Prostate Cancer Care, Study Contends

Oct. 22, 2015 (HealthDay News) -- Older black men with prostate cancer seem more likely to receive poorer quality of care that costs more compared to white men, a new study found. Although there was no difference between the races in survival from prostate cancer, black men had to wait.


Men’s Health Supplements Don’t Benefit Prostate Cancer Patients: Study

Oct. 19, 2015 (HealthDay News) -- A new study finds no evidence that men's health supplements help prostate cancer patients. Although popular, such supplements do not appear to lower the risk for experiencing radiation treatment side effects; the risk that localized cancer will spread; or the risk that prostate cancer.


Relaxed Guidelines on PSA Testing Might Miss Aggressive Tumors: Study

Sept. 22, 2015 (HealthDay News) -- Relaxed guidelines on prostate cancer screening may delay diagnosis and treatment of aggressive tumors, a new study suggests. In 2011, the U.S. Preventive Services Task Force recommended against routine prostate specific antigen (PSA) testing, to curb over-diagnosis and overtreatment of prostate cancer. Since then,.


Some Prostate Cancer Patients May Not Benefit from Hormone Therapy

Sept. 22, 2015 (HealthDay News) -- Men with prostate cancer who also have had a heart attack may fare better with radiation therapy alone rather than with the standard treatment of radiation plus hormone therapy, a new analysis suggests. Over an average of 17 years of follow-up, men with high-risk.


Obesity Linked to Greater Risk of Prostate Cancer in Blacks, Study Says

April 16, 2015 (HealthDay News) -- Blacks have a higher risk of developing prostate cancer than whites, and for obese black men, their risk can quadruple as their weight goes up, a new study indicates. The findings from this large study should lead to a redoubling of efforts to encourage.